Jianqiang Wu

3.1k total citations
48 papers, 1.7k citations indexed

About

Jianqiang Wu is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jianqiang Wu has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Jianqiang Wu's work include Neurofibromatosis and Schwannoma Cases (29 papers), Neuroblastoma Research and Treatments (22 papers) and Sarcoma Diagnosis and Treatment (16 papers). Jianqiang Wu is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (29 papers), Neuroblastoma Research and Treatments (22 papers) and Sarcoma Diagnosis and Treatment (16 papers). Jianqiang Wu collaborates with scholars based in United States, China and Australia. Jianqiang Wu's co-authors include Nancy Ratner, Tilat A. Rizvi, Edwin Jousma, Eva Dombi, José A. Cancelas, Mi‐Ok Kim, Timothy P. Cripe, Jon Williams, Anat Stemmer‐Rachamimov and Kwangmin Choi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Jianqiang Wu

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianqiang Wu United States 23 914 524 485 187 185 48 1.7k
Zhiguo Chen United States 19 356 0.4× 242 0.5× 726 1.5× 209 1.1× 92 0.5× 41 1.4k
Carlo Dominici Italy 27 508 0.6× 383 0.7× 1.2k 2.4× 445 2.4× 175 0.9× 57 1.9k
Maria Michiara Italy 21 277 0.3× 378 0.7× 345 0.7× 618 3.3× 144 0.8× 81 1.6k
Veena Rajaram United States 21 240 0.3× 314 0.6× 784 1.6× 203 1.1× 142 0.8× 60 1.6k
Yanlin Yu United States 18 192 0.2× 194 0.4× 913 1.9× 377 2.0× 62 0.3× 35 1.5k
Tong Sun China 22 185 0.2× 192 0.4× 1.2k 2.4× 414 2.2× 161 0.9× 61 2.0k
Peter Dirks Canada 15 424 0.5× 114 0.2× 295 0.6× 170 0.9× 118 0.6× 31 935
Simone Hettmer Germany 23 123 0.1× 508 1.0× 714 1.5× 270 1.4× 54 0.3× 62 1.3k
Kiyotaka Yokogami Japan 17 237 0.3× 298 0.6× 656 1.4× 393 2.1× 344 1.9× 70 1.5k
Annalisa Pezzolo Italy 24 540 0.6× 159 0.3× 965 2.0× 566 3.0× 91 0.5× 68 1.9k

Countries citing papers authored by Jianqiang Wu

Since Specialization
Citations

This map shows the geographic impact of Jianqiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqiang Wu more than expected).

Fields of papers citing papers by Jianqiang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqiang Wu. The network helps show where Jianqiang Wu may publish in the future.

Co-authorship network of co-authors of Jianqiang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqiang Wu. A scholar is included among the top collaborators of Jianqiang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqiang Wu. Jianqiang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmari, Niousha, Kwangmin Choi, Jianqiang Wu, et al.. (2025). Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas. Life Science Alliance. 8(12). e202503359–e202503359.
2.
Ahmari, Niousha, Jay Pundavela, Sara Szabo, et al.. (2024). C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis. Life Science Alliance. 7(5). e202302229–e202302229. 4 indexed citations
3.
Wang, Chen, Xiongwei Cai, Weinan Wang, et al.. (2023). A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation. Blood Advances. 7(11). 2590–2605. 10 indexed citations
4.
Yu, Yanan, Liang Hu, Kwangmin Choi, et al.. (2023). Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis. Oncogene. 42(13). 1038–1047. 7 indexed citations
5.
Zheng, Fei, Xiaohui Ma, Jianqiang Wu, et al.. (2022). Assessment of Thigh MRI Radiomics and Clinical Characteristics for Assisting in Discrimination of Juvenile Dermatomyositis. Journal of Clinical Medicine. 11(22). 6712–6712. 3 indexed citations
6.
Teng, Liping, et al.. (2022). Epstein-Barr virus infection associated polymyositis and coronary artery dilation. BMC Infectious Diseases. 22(1). 227–227. 1 indexed citations
7.
Patel, Ami V., Jianqiang Wu, Kwangmin Choi, et al.. (2020). Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. Cancer Research. 80(21). 4720–4730. 26 indexed citations
8.
Choi, Kwangmin, Liang Hu, Robert F. Hennigan, et al.. (2020). MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK. Oncogene. 40(5). 951–963. 18 indexed citations
9.
Wu, Jianqiang, Meiping Lu, & Ann M. Reed. (2019). Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World Journal of Pediatrics. 16(1). 31–43. 35 indexed citations
10.
Wu, Lai Man Natalie, Yaqi Deng, Jincheng Wang, et al.. (2018). Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. Cancer Cell. 33(2). 292–308.e7. 88 indexed citations
11.
Choi, Kwangmin, Edwin Jousma, Tilat A. Rizvi, et al.. (2018). STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma. Oncogene. 38(15). 2876–2884. 44 indexed citations
12.
Wu, Jianqiang. (2016). Molecular mechanism of autophagy in autoimmune disease. International journal of pediatrics. 43(1). 5–9. 1 indexed citations
13.
Li, Hui, Xin Zhao, Xiaomei Yan, et al.. (2015). Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. Oncogene. 35(11). 1468–1474. 15 indexed citations
14.
Patmore, Deanna M., Sara Welch, Patricia C. Fulkerson, et al.. (2012). In Vivo Regulation of TGF-β by R-Ras2 Revealed through Loss of the RasGAP Protein NF1. Cancer Research. 72(20). 5317–5327. 18 indexed citations
15.
Wu, Jianqiang, Eva Dombi, Edwin Jousma, et al.. (2011). Preclincial testing of Sorafenib and RAD001 in the Nfflox/flox;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging. Pediatric Blood & Cancer. 58(2). 173–180. 48 indexed citations
16.
Williams, Jon, Jianqiang Wu, Gunnar Johansson, et al.. (2008). Nf1 Mutation Expands an EGFR-Dependent Peripheral Nerve Progenitor that Confers Neurofibroma Tumorigenic Potential. Cell stem cell. 3(6). 658–669. 33 indexed citations
17.
Wu, Jianqiang, Jon Williams, Tilat A. Rizvi, et al.. (2008). Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing Cells. Cancer Cell. 13(2). 105–116. 166 indexed citations
18.
Ling, Benjamin, Jianqiang Wu, Shyra J. Miller, et al.. (2005). Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell. 7(1). 65–75. 99 indexed citations
19.
Wu, Jianqiang, Yifang Wang, Weihong Xiao, et al.. (2004). Assessment of Recombinant Porcine Follicle‐Stimulating Hormone Receptor Using a Novel Polyclonal Ectodomain Antibody. Endocrine Research. 30(2). 269–285. 2 indexed citations
20.
Wu, Jianqiang, Nathaniel Harris, & Thomas H. Inge. (2004). Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. Journal of Surgical Research. 122(2). 231–239. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiguo Chen Breakdown of academic impact, for papers by Carlo Dominici Breakdown of academic impact, for papers by Maria Michiara Breakdown of academic impact, for papers by Veena Rajaram Breakdown of academic impact, for papers by Yanlin Yu Breakdown of academic impact, for papers by Tong Sun Breakdown of academic impact, for papers by Peter Dirks Breakdown of academic impact, for papers by Simone Hettmer Breakdown of academic impact, for papers by Kiyotaka Yokogami Breakdown of academic impact, for papers by Annalisa Pezzolo
Rankless by CCL
2026